151 related articles for article (PubMed ID: 18661339)
1. Dysregulation of matrix metalloproteinases and their tissue inhibitors by S100A4.
Elenjord R; Ljones H; Sundkvist E; Loennechen T; Winberg JO
Connect Tissue Res; 2008; 49(3):185-8. PubMed ID: 18661339
[TBL] [Abstract][Full Text] [Related]
2. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by upregulation of S100A4/MMPs signaling.
Cao WH; Liu HM; Liu X; Li JG; Liang J; Liu M; Niu ZH
Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):609-17. PubMed ID: 23543443
[TBL] [Abstract][Full Text] [Related]
3. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.
Bjørnland K; Winberg JO; Odegaard OT; Hovig E; Loennechen T; Aasen AO; Fodstad O; Maelandsmo GM
Cancer Res; 1999 Sep; 59(18):4702-8. PubMed ID: 10493528
[TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinases and the metastasis-associated gene S100A4 in human neuroblastoma and primitive neuroectodermal tumor cells.
Bjørnland K; Bratland A ; Rugnes E; Pettersen S; Johansen HT; Aasen AO; Fodstad Ø; Ree AH; Maelandsmo GM
J Pediatr Surg; 2001 Jul; 36(7):1040-4. PubMed ID: 11431772
[TBL] [Abstract][Full Text] [Related]
5. S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases.
Senolt L; Grigorian M; Lukanidin E; Simmen B; Michel BA; Pavelka K; Gay RE; Gay S; Neidhart M
Ann Rheum Dis; 2006 Dec; 65(12):1645-8. PubMed ID: 17105852
[TBL] [Abstract][Full Text] [Related]
6. Spatiotemporal expression of matrix metalloproteinases (MMPs) is regulated by the Ca2+-signal transducer S100A4 in the pathogenesis of thoracic aortic aneurysm.
Cao J; Geng L; Wu Q; Wang W; Chen Q; Lu L; Shen W; Chen Y
PLoS One; 2013; 8(7):e70057. PubMed ID: 23922901
[TBL] [Abstract][Full Text] [Related]
7. [Matrix metalloproteinases and their tissue inhibitors].
Trojanek J
Postepy Biochem; 2012; 58(3):353-62. PubMed ID: 23373420
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of metastasis-promoting S100A4 (Mts-1) in rheumatoid arthritis: putative involvement in the pathogenesis of rheumatoid arthritis.
Klingelhöfer J; Senolt L; Baslund B; Nielsen GH; Skibshøj I; Pavelka K; Neidhart M; Gay S; Ambartsumian N; Hansen BS; Petersen J; Lukanidin E; Grigorian M
Arthritis Rheum; 2007 Mar; 56(3):779-89. PubMed ID: 17328050
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion.
Bourboulia D; Stetler-Stevenson WG
Semin Cancer Biol; 2010 Jun; 20(3):161-8. PubMed ID: 20470890
[TBL] [Abstract][Full Text] [Related]
10. The TIMPs tango with MMPs and more in the central nervous system.
Crocker SJ; Pagenstecher A; Campbell IL
J Neurosci Res; 2004 Jan; 75(1):1-11. PubMed ID: 14689443
[TBL] [Abstract][Full Text] [Related]
11. [Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis].
Fiedorczyk M; Klimiuk PA; Sierakowski S; Kita K
Pol Merkur Lekarski; 2006 Feb; 20(116):228-31. PubMed ID: 16708647
[TBL] [Abstract][Full Text] [Related]
12. Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro.
Cui JF; Liu YK; Zhang LJ; Shen HL; Song HY; Dai Z; Yu YL; Zhang Y; Sun RX; Chen J; Tang ZY; Yang PY
Proteomics; 2006 Nov; 6(22):5953-61. PubMed ID: 17051636
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
Bode W; Maskos K
Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
Visse R; Nagase H
Circ Res; 2003 May; 92(8):827-39. PubMed ID: 12730128
[TBL] [Abstract][Full Text] [Related]
15. The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer.
Groblewska M; Siewko M; Mroczko B; Szmitkowski M
Folia Histochem Cytobiol; 2012 Apr; 50(1):12-9. PubMed ID: 22532131
[TBL] [Abstract][Full Text] [Related]
16. Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies.
Hemmann S; Graf J; Roderfeld M; Roeb E
J Hepatol; 2007 May; 46(5):955-75. PubMed ID: 17383048
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
Gueders MM; Foidart JM; Noel A; Cataldo DD
Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
[TBL] [Abstract][Full Text] [Related]
18. Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy.
Sherbet GV
Cancer Lett; 2009 Jul; 280(1):15-30. PubMed ID: 19059703
[TBL] [Abstract][Full Text] [Related]
19. Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB/c mouse brain challenged with Japanese encephalitis virus.
Shukla V; Kumar Shakya A; Dhole TN; Misra UK
Neuroimmunomodulation; 2012; 19(4):241-54. PubMed ID: 22441541
[TBL] [Abstract][Full Text] [Related]
20. The role of TIMPs in regulation of extracellular matrix proteolysis.
Arpino V; Brock M; Gill SE
Matrix Biol; 2015; 44-46():247-54. PubMed ID: 25805621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
